Squarepoint
TMO icon

Squarepoint’s Thermo Fisher Scientific TMO Stock Holding History

Squarepoint’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1M Buy
40,800
+32,300
+380% +$17.5M 0.02% 710
2025
Q4 		$4.93M Sell
8,500
-70,900
-89% -$40.1M 0.01% 1468
2025
Q3 		$38.5M Sell
79,400
-10,100
-11% -$4.7M 0.04% 493
2025
Q2 		$36.3M Buy
89,500
+76,400
+583% +$31.9M 0.04% 498
2025
Q1 		$6.52M Buy
13,100
+4,400
+51% +$2.38M 0.01% 1274
2024
Q4 		$4.53M Sell
8,700
-8,000
-48% -$4.4M ﹤0.01% 1720
2024
Q3 		$10.3M Buy
16,700
+6,100
+58% +$3.61M 0.02% 945
2024
Q2 		$5.86M Sell
10,600
-61,500
-85% -$35.2M 0.01% 1268
2024
Q1 		$41.9M Buy
72,100
+65,200
+945% +$36.6M 0.07% 316
2023
Q4 		$3.66M Buy
+6,900
New +$3.34M 0.01% 1596
2023
Q3 		– Sell
-21,300
Closed -$11.1M – 4252
2023
Q2 		$11.1M Buy
21,300
+20,400
+2,267% +$11M 0.03% 609
2023
Q1 		$519K Sell
900
-5,900
-87% -$3.33M ﹤0.01% 2277
2022
Q4 		$3.74M Sell
6,800
-100
-1% -$53K 0.01% 980
2022
Q3 		$3.5M Hold
6,900
– – 0.02% 962
2022
Q2 		$3.75M Sell
6,900
-2,700
-28% -$1.49M 0.02% 828
2022
Q1 		$5.67M Buy
9,600
+9,200
+2,300% +$5.28M 0.02% 674
2021
Q4 		$267K Buy
+400
New +$250K ﹤0.01% 2517
2021
Q1 		– Sell
-700
Closed -$326K – 3619
2020
Q4 		$326K Hold
700
– – ﹤0.01% 2144
2020
Q3 		$309K Buy
+700
New +$289K ﹤0.01% 1770

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Squarepoint's TMO Position: Q1 2026 in Review

Squarepoint increased its Thermo Fisher Scientific (TMO) stake by 598% in Q1 2026, buying an estimated $32.5M and bringing the position to 69,837 shares worth $34.3M. The position accounts for 0.04% of the portfolio, ranked #466.

Squarepoint first reported a position in TMO in Q2 2015 and has held it in 34 quarters since. The position peaked at $166M in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Squarepoint held 69,837 shares of Thermo Fisher Scientific worth $34.3M as of Q1 2026.
  • Squarepoint bought 59,825 Thermo Fisher Scientific shares in Q1 2026, an estimated $32.5M.
  • Thermo Fisher Scientific made up 0.04% of Squarepoint's portfolio in Q1 2026, its #466 holding.
  • Squarepoint first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 34 quarters since.
  • Squarepoint's Thermo Fisher Scientific position peaked at $166M in Q2 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.